IFN-γ, a type II IFN, is involved in the most frequent pathways that have been identified in the pathogenic processes of human SS [16], although three distinct patterns of IFN were evident: type I-predominant, type II-predominant, and type I/II mixed IFN among those patients. The gene discussed is IFNG; the disease is synovial sarcoma.